Cell Therapeutics (CTIC) Files 12.61M Common Shelf for Shareholders
Tweet
Share
E-mailGet Alerts CTIC Hot Sheet
Join SI Premium – FREE
Cell Therapeutics, Inc. (Nasdaq: CTIC) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to 12,605,042 shares of Common Stock on behalf of Selling Shareholders.
Cell Therapeutics will not receive proceeds from the secondary offering.
Cell Therapeutics will not receive proceeds from the secondary offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Londian Wason prices IPO at $22 per ADS, raising $94.3 million
- NeOnc Phase 2a brain cancer trial shows 48.9% survival vs. 20% benchmark
- SEC files civil complaint against Netcapital and certain individuals
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
